QIAGEN Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next-Generation, Fully Integrated Multiplex Platform for Syndromic Disease Testing
Go back to QIAGEN Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next-Generation, Fully Integrated Multiplex Platform for Syndromic Disease Testing| Qiagen NV (NYSE: QGEN) | Delayed: 42.50 -0.97 (2.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.47 | 52 Week High | $28.50 | |||
| Open | $42.40 | 52 Week Low | $19.94 | |||
| Day High | $42.70 | P/E | 146.55 | |||
| Day Low | $42.30 | EPS | $0.29 | |||
| Volume | 125,042 | |||||
| (NYSE: QIA) | Delayed: 0.00 -10.35 (100%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.35 | 52 Week High | $ | |||
| Open | $10.35 | 52 Week Low | $ | |||
| Day High | $10.35 | P/E | N/A | |||
| Day Low | $10.35 | EPS | $ | |||
| Volume | 0 | |||||
